Kendall Davis

Director of Advocacy & Engagement Strategy, Center for Rare Diseases

Kendall Davis is a Patient Advocacy and Engagement Strategist; specializing is rare disease clinical drug development and the life sciences. She is a passionate rare disease advocate dedicated to empowering patients, advocacy organizations, researchers, and industry, by developing new innovative strategies to meet advocacy, engagement, educational and business needs to catalyze rare disease drug development. She is a strategic thinker with excellent collaboration and problem-solving skills as well as a strong business acumen. Kendall has held key roles in patient advocacy in both the nonprofit and biopharmaceutical industries including with Global Genes, Spark Therapeutics and PRA Health Sciences (now ICON). Kendall specializes in cultivating partnerships with patient advocacy organizations, identifying and partnering with Key Opinion and Community Leaders, identifying key business needs, developing customized strategies to achieve key outcomes, and balancing a global focus with national, regional, and local patient centric partnerships. Kendall works with leaders in the rare disease nonprofit community & biotechnology space to advance rare disease drug development. Kendall serves as a strategic advisor/board member to the Team Telomere organization and to the Rare and Undiagnosed Network. She has a Masters Degree in Public Heath from Michigan State University and a Bachelor’s of Science in Psychology from Loyola University, Chicago.

Talks About
#strategy #engagement #biotech

Preferred Locations
#Northamerica